Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Koning Corporation
Age
40–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Group I:
Are at least 40 years of age of any ethnicity
Had a mammogram, read as BI-RADS® 1 or 2
Will undergo study imaging no later than four weeks from date of mammogram.
Is able to undergo informed consent.
Group II:
Are at least 40 years of age of any ethnicity
Had a routine mammogram, read as BI-RADS® 4 or 5
Are scheduled for breast biopsy
Will undergo study imaging no later than four weeks from date of mammogram, prior to breast biopsy.
Is able to undergo informed consent.
Group III:
Are at least 40 years of age of any ethnicity
Had a routine mammogram, read as BI-RADS® 4 or 5
Are scheduled for breast biopsy
Will undergo study imaging no later than four weeks from date of mammogram, prior to breast biopsy.
Is able to undergo informed consent.
You may not be if
Group I and Group II:
Pregnancy
Lactation
Subjects with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.
Subjects who are unable to tolerate study constraints.
Subjects who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to)
* Treatment for enlarged thymus gland as an infant
* Irradiation for benign breast conditions, including breast inflammation after giving birth
* Treatment for Hodgkins disease
Subjects who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.
Subjects who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to)
* Tuberculosis
* Severe scoliosis
Group III:
Pregnancy
Lactation
Subjects with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.
Subjects who are unable to tolerate study constraints.
Subjects who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to)
* Treatment for enlarged thymus gland as an infant
* Irradiation for benign breast conditions, including breast inflammation after giving birth
* Treatment for Hodgkins disease
Subjects who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.
Subjects who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to)
* Tuberculosis
* Severe scoliosis
Allergy or previous reaction to iodinated contrast material
